“Increase in adoption of minimally invasive spine surgery (MISS) presents lucrative opportunities for key players in the spinal fusion devices market. MISS is preferred to conventional techniques, owing to its associated benefits such as minimal cut or incision, which in turn reduces the chances of damage caused to the adjacent muscles.”
Global Spinal Fusion Devices Market was valued at $5.86 billion in 2015, and is expected to reach $7.43 billion by 2022, with a CAGR of 3.4% during study period 2016-2022.
Spine fusion devices are used to treat the disorders associated with the spine. These devices restore the functionality and maintain the normal alignment of the spine. Spine fusion devices are categorized into thoracolumbar devices, cervical fixation devices, and interbody fusion devices.
Download Sample Copy of this Report @ https://www.alliedmarketresearch.com/request-sample/1956
The global spinal fusion devices market is driven by factors such as advent of minimally invasive spine surgery techniques and rise in incidence of spinal disorders. In addition, surge in geriatric population is anticipated to fuel the demand for spinal fusion devices, globally. However, unfavorable reimbursement scenario and stringent regulatory approval process hamper the market growth.
The thoracolumbar fusion devices segment generated the highest revenue in the global market, and accounted for more than two-fifths share of the global market. In addition, the interbody fusion devices segment is expected to grow at a CAGR of 3.6% during the forecast period.
North America accounted for the majority revenue share in 2015, and is expected to maintain this trend during the forecast period. However, the Asia-Pacific region is projected to grow rapidly, registering a CAGR of 4.6% during the forecast period. Improving healthcare infrastructure and increase in expenditures in the emerging markets, such as India and China, to cater to the unmet medical needs in these countries have bolstered the market growth.
The key players in the spinal fusion devices market have focused on expanding their business operations in the fast-growing economies by adopting the product launch strategy. The major companies profiled in the report include Alphatec Holdings, Inc., B. Braun Melsungen AG, Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., Stryker Corporation, and Zimmer Biomet Holdings, Inc.
Check available discounts on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/1956
Spinal Fusion Devices Market Key Findings:
- France and Germany jointly accounted for almost two-fifths share of the European spinal fusion devices market in 2015.
- Japan was the major shareholder in the Asia-Pacific spinal fusion devices market, accounting for more than one-third share in 2015.
- The spinal fusion market in India is poised to grow at a CAGR of 6.2% during the forecast period.
- The interbody fusion devices segment is expected to grow at a CAGR of 3.6%, owing to the ability to conduct spinal fusion with less post-operative discomfort.
- The non-bone interbody fusion devices segment accounted for more than two-thirds share of the global interbody fusion devices market in 2015.
Scope of The Report:
| Report Attribute | Details |
| Market size available for years | 2015-2022 |
| Base year considered | 2015 |
| Forecast period | 2014-2022 |
| Forecast units | Value (USD) |
| Segments covered | Product, and Surgery |
| Geographies covered | North America, Europe, Asia-Pacific, LAMEA |
Related Reports:
Cytogenetics Market by Product (Consumables, Instruments, and Software & Services), Technique (Comparative Genomic Hybridization, Fluorescence in Situ Hybridization (FISH), Karyotyping, Immunohistochemistry, and Others), Application (Genetic Disorders, Cancer, Personalized Medicine, and Others), and End User (Clinical & Research Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Institutes, and Others) – Global Opportunity Analysis and Industry Forecast, 2018-2025
Transcriptomics Market by Technology (Microarray, Real-time PCR, and Sequencing Technology), Products & Services (Consumables, Instruments, Software, and Services), Application (Diagnostics & Disease Profiling, Drug Discovery, and Others), and End User (Government Institutes & Academic Centers, Pharmaceutical & Biotechnology Companies, and Contract Research Organization) – Global Opportunity Analysis and Industry Forecast, 2017-2023
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research
Follow Us on Twitter: https://twitter.com/marketresearcht
